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OBJECTIVE: The aim of this study was to investigate bone repair after the implantation of vancomycin-loaded poly-
L-lactic acid/poly-ethylene oxide microspheres compared with vancomycin-unloaded poly-L-lactic acid/poly-ethylene
oxide microspheres.
METHODS: Poly-L-lactic acid/poly-ethylene oxide microspheres were implanted in rat tibiae and evaluated for
periods of 2, 4, 8, and 12 days and 4, 8, 16, and 32 weeks. The groups implanted with vancomycin-loaded and
vancomycin-unloaded microspheres were compared. Histopathologic (semi-quantitative) and histomorphometric
analyses were performed to evaluate the bone formation process.
RESULTS: During the first period (second day), fibrin and hemorrhaging areas were observed to be replaced by
granulation tissue around the microspheres. Woven bone formation with progressive maturation was observed. All
of the histopathological findings, evaluated by a semi-quantitative assay and a quantitative analysis (percentage of
bone formation), were similar between the two groups.
CONCLUSION: Vancomycin-loaded poly-L-lactic acid/poly-ethylene oxide microspheres are a good bone substitute
candidate for bone repair. Local antibiotic therapy using vancomycin-loaded poly-L-lactic acid/poly-ethylene oxide
microspheres should be considered after the microbiological evaluation of its efficacy.
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INTRODUCTION
Due to the limitations of bone grafts (1,2), synthetic
materials for orthopedic use have become a focus of
scientific studies. These products can replace or aid bone
grafting for bone healing. Thus, many polymers have been
studied. Polymethylmethacrylate (PMMA) is one of the
most commonly used polymers as a bone cement. It is also
sometimes applied as a substitute for bone grafts; however,
this type of polymer is mechanically weak and requires high
temperatures for synthesis, which can therefore cause tissue
necrosis (2).
Bioabsorbable polymeric materials are potential candi-
dates for replacing metallic, ceramic, and polymeric non-
bioabsorbable materials. Additionally, when manufactured
together with those materials, they can enhance the osteo-
integration processes (3-10). Poly-L-lactic acid (PLLA) is a
bioabsorbable polymer that is widely investigated for its
use in drug delivery systems, surgical sutures, and bone
fracture fixation materials (11). However, due to a very slow
degradation rate, this polymer may be undesirable for some
applications (12). Thus, polymeric blends, such as the blend
of PLLA with poly-ethylene oxide (PEO), have been used to
control the PLLA degradation rate. PEO is a biomaterial
known for its biocompatibility and low toxicity (4). Corac¸a
et al. (13) observed the crack formation in PLLA/PEO pins
after implantation in rat tibia, which allowed tissue growth
into the implant and improved the bone interaction
compared with pure PLLA implants. PLLA is a Food and
Drug Administration (FDA)-approved material that can be
implanted or administered by injection (14,15).
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In addition to the positive results with PLLA and PEO,
infections associated with metal and polymeric surfaces or
dead tissues, such as bone grafts, can still be fatal for the
patient and represent a major financial burden for the
economy. The adhering bacteria in these cases can evade
host defenses by forming biofilms. Therefore, the prevention
of bacterial colonization is of great interest. Injury to the
surrounding tissue is unavoidable during implantation,
resulting in impaired blood circulation in this area and
triggering an inflammatory reaction. Bacteria are more apt
to colonize the surface of the implant, where the host’s
defense is weakened and the blood supply is insufficient.
When antibiotics are administered systemically, they do
not reach a high therapeutic level in the area directly sur-
rounding the implant, rendering long-term high doses of
antibiotics unsuccessful in most cases (16). When examining
the relationship among the implant, the host and bacteria,
competition for the colonization of the implant surface can
be observed. If the body’s own cells are the first to colonize
the surface, they form a cell ‘‘lawn’’ of connective tissue,
which makes adhering to the surface difficult for the
bacteria and thus effectively protects the implant from
infections. If, however, the bacteria colonize the surface first,
they can, similar to the body’s own cells, form a biofilm that
protects itself from host immune cells. This phenomenon is
called the ‘‘race for surface’’ (17).
The aim of this study was to investigate bone repair using
implants of vancomycin-loaded and vancomycin-unloaded
PLLA/PEO microspheres as a bone graft substitute and
possible carriers of antibiotics for local therapy. The micro-
spheres containing vancomycin should not impair the
process of bone healing.
MATERIALS AND METHODS
Animals
A total of 80 adult (eight weeks old) male Wistar rats were
divided into two groups as follows: 40 animals were
implanted with vancomycin-loaded PLLA/PEO micro-
spheres and 40 animals were implanted with vancomycin-
unloaded PLLA/PEO microspheres as a control. Although
the objective of this study was the evaluation of bone
healing in the presence of vancomycin-loaded implants, no
tests for spontaneous bone healing were performed. During
the experimental period, the animals remained in plastic
cages under controlled light and ventilation, receiving solid
food (Nuvilab CR-1 from Nuvital) and water ad libitum. The
study was carried out with the approval of the Ethical
Committee of Animal Research (CEEA/Unicamp Protocol
n. 339-1) of the Campinas State University, Sa˜o Paulo, Brazil.
Production of the microspheres
Pure PLLA and pure PEO granulates (Sigma Aldrich)
were mixed in a ratio of 80:20 and melted in a Mini Max
Molder LMM-2017 injector (Custom Scientific Instruments,
Inc., Whippany, NJ). The polymer was heated inside a mold
and stirred for gravity collection. The resulting stick blend
was cooled at room temperature. Half a gram of the 80:20
PLLA/PEO blend was dissolved in 10 ml of dichloro-
methane (DCM). Vancomycin was added to the polymeric
solution (0.75 ml) and mixed to create an emulsion. To
gather the microspheres, the emulsion was placed in a 2%
isopropanol solution. The solution was vortexed until total
DCM evaporation occurred, and the microspheres were
collected from the supernatant and vacuum dried. The
microspheres, sized 100-200 mm in diameter, were com-
pressed to facilitate their use during surgery.
Surgical procedures
The animals were anesthetized before the surgical
procedure to create the defects. The anesthesia was induced
interperitoneally with 0.1 mg/100 mg body weight keta-
mine (KetalarH, Pfizer, Guarulhos, Brazil) and 0.08 mg/
100 mg body weight xylazine (RompunH, Bayer, Sao Paulo,
Brazil). Under anesthesia, a longitudinal incision was made
in the skin above the proximal portion of the left tibia. The
muscle tissue was retracted, and the bone was exposed. An
odontological drill was used to create a cavity (3-mm
diameter) in the tibia. During this process, the area was
continuously irrigated with a saline solution to avoid
overheating. The cavity was filled with the microspheres,
and the muscle and skin were sutured. In each group, 40
animals were divided into subgroups of five animals for
each experimental period (2, 4, 8, and 12 days and 4, 8, 16,
and 32 weeks). No animals died during these periods. At the
end of each period, the animals belonging to each subgroup
were euthanized by an overdose of anesthesia, and the
implanted tibia was removed for histological evaluation.
Table 1 - Estimated histopathological features used in the semi-quantitative analysis.
Items Intensity
Absence (0) Light (1) Moderate (2) Intense (3)
Granulation Tissue
(HE 106)
- Occupying up to 1/3 of
the microscopic field
Occupying up to 2/3 of
the microscopic field
Occupying from 2/3 to all of the microscopic field
Acute Inflammation
(HE 406)
- Occupying up to 1/3 of
the microscopic field
Occupying up to 2/3 of
the microscopic field
Occupying from 2/3 to all of the microscopic field
Bone Formation - Around the microspheres Around and partially
filling the center of
the microspheres
Around and completely filling the center of the
microspheres
Item Intensity




Dense connective tissue Connective tissue with
partial ossification
Total ossification
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Microscopic evaluation and morphometric analysis
The removed tibiae were fixed in 37% formalin, decalci-
fied in ethylenediaminetetraacetic acid (EDTA) solution and
submitted to histological analysis. The sections were stained
with hematoxylin/eosin and Masson’s trichrome stain.
Conventional light microscopy was used for the histopa-
thological evaluation. Qualitative (descriptive) and semi-
quantitative analyses were used according to the following
criteria (Table 1).
For thehistomorphometric analysis, theMasson’s trichrome-
stained sections were photographed, and the images were
analyzed with the software Image LabH (ImageLab, Sao
Paulo, Brazil). The results were used to measure the new
bone formed (%) around the implant (microspheres).
Statistical analysis
The Mantel-Haenszel test was used to compare the
different levels of intensity obtained by the morphometric
(semi-quantitative) assessments. The co-variance analysis
andMann-Whitney test were used to compare the differences
between the percentages of bone formation around the
microspheres during the experimental periods, as obtained
by the histomorphometric analysis. p-values of 0.05 or lower
were considered statistically significant. SPSS 17.0 (SPSS
Inc., Chicago, IL, USA) was used for the statistical analysis.
The software GraphPadH Prism 5.01 (GraphPad Software
Inc., La Jolla, CA, USA) was used to create the graphs.
RESULTS
Microscopic findings
The microscopic findings were similar in both groups
throughout the experimental periods. The vancomycin-loaded
and vancomycin-unloaded PLLA/PEO microspheres were
easily visible inside themedullary cavity in both groupsduring
all evaluatedperiods (Figures 1, 2, and 3).After twodays, fibrin
and hemorrhaging were visibly close to the implant in the
medullary cavity and were replaced by granulation tissue on
approximately the fourth day (Figure 1A).
In addition, a loose interstitial connective mesh was
observed wrapped around the microspheres. Septa of a
connective-like tissue were observed invading the spaces
between the microspheres. Those septa were comprised
of fibroblast-like mesenchymal elements with osteoblast
differentiation and endothelial-like cells that created vas-
cular lumens. Discrete inflammatory cell foci with neutro-
philic predomination were observed only during the initial
period (two and four days). On the fourth day, the
proliferation of initial immature bone formation (woven
bone) was observed around the cluster of microspheres,
Figure 1 - Histology of a tibia implanted with vancomycin-loaded
microspheres composed of PLLA/PEO: A) implant on the 4th day,
characterized by exuberant granulation tissue around the micro-
spheres (Original H&E 206); B) implant on the 12th day, showing
remodeling into woven bone characterized by osteoblastic (arrow
right) and osteoclastic (arrow left) activity (Original TM 406); and
C and D) implants on the 8th day, characterized by woven bone
surrounding the microspheres that becomes mature when
composed of lamellar bone at 32 weeks (Original TM 106).
Figure 2 - Histology of tibias implanted with PLLA/PEO that were
A) vancomycin-loaded or B) vancomycin-unloaded on the 4th day,
showing evident granulation tissue around the microspheres
(arrow) with the initial replacement by bone formation (arrow).
This figure also shows the histology of the tibias of animals
implanted after 12 days with PLLA/PEO that were C) vancomycin-
loaded or D) vancomycin-unloaded, showing trabecular bone
encasing the microspheres (Original H&E 106).
Figure 3 - Histology of tibias implanted with PLLA/PEO that were
A) vancomycin-loaded or B) vancomycin-unloaded after 4 weeks,
showing thin trabecular bone (arrow); and PLLA/PEO that were
C) vancomycin-loaded or D) vancomycin-unloaded during a 32-
week period, showing massive bone formation surrounding the
microspheres with evident maturation and the presence of
lamellar bone (arrow) (Original H&E 106).
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gradually replacing the granulation tissue and the interstitial
connective septa (Figures 2A and 2B) and becoming abundant
in the eight-week implants (Figure 1C). On approximately the
12th day, obvious trabecular bone was observed around the
microspheres (Figures 2C and 2D). This period was also
characterized by bone remodeling with intense osteoblast
and osteoclast activity (Figure 1B). Thin trabecular bone was
observed in the fourth week (Figures 3A and 3B). After this
event, gradual bone maturation was observed with lamellar-
like bone centripetally in the microsphere group, which had
the thickness of trabecular bone. In the final periods, a
completely mature ossification of the septum inside the
implant and around each microsphere was observed
(Figures 3C and 3D). This ossification formed a capsule
encasing the implant. Tissue rejection signals, such as thick
fibrous capsules or necrosis, were not observed.
Histopathological (semi-quantitative) analysis
The level of intensity for each item evaluated by the
histopathological (semi-quantitative) analysis (Figure 4 and
Figure 4 - Histopathological (semi-quantitative) analysis: 0 = absent, 1 = light, 2 =moderate and 3= intense. The periods that showed no
values are equivalent to 0=absent.
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5) did not exhibit any significant differences between the
vancomycin-loaded and vancomycin-unloaded PLLA/PEO
microsphere groups.
Histomorphometric analysis
The percentage of bone formation was similar between the
vancomycin-loaded and vancomycin-unloaded PLLA/PEO
microsphere groups. However, a significant difference in the
bone formation was noted over the course of the entire
experimental period (p#0.05). The bone formation increased
gradually during the four earliest experimental periods and
stabilized in approximately the fourth week. Subsequently,
the bone formation process underwent a maturation phase
that continued into the last period (Figure 6).
DISCUSSION
The PLLA/PEO blend was selected for this study due to
its well-known biocompatibility (5,13). Vancomycin was
added to the PLLA/PEO blend because of its common use
as a local therapy for bone infection (18).
After implantation, the microspheres remained inside the
medullar cavity in all animals. This result may be explained
first by the connective and bone tissue proliferation
encasing the microspheres and, second, by the long-term
degradation of the PLLA (12). The inflammatory process
was mild and present only during the initial periods (from 2
to 4 days) with neutrophilic predominance, a characteristic
process of tissue repair.
A mild inflammatory reaction with giant cells was
observed without edema, and, therefore, the bone regen-
eration was not affected. Beginning on the fourth day
after the implantation, the areas of fibrin and hemorrhage,
organized in the granulation and fibrous connective tissue,
were gradually replaced by bone. The bone grew between
the individual microspheres, encasing the implant. This
finding demonstrated the characteristic osteointegration
capacity of this material. Ueng et al. (20) detected this
reaction in rabbits loaded with vancomycin-loaded poly
(L-lysine) (PLL) beads, which were encased by bone after
eight weeks.
The osteointegration process in the present study was
better for PLLA/PEO microspheres compared with PLLA/
PEO molded as pins (13). This result can likely be attributed
to the sphere morphology, which permits more tissue
interaction with the bone formation that occurs not only
around but also inside the implant and in between the
microspheres. Another advantage of the microsphere
morphology is that it facilitates the use of beads in surgical
bone cavities. Furthermore, the microspheres do not need to
be cast in advance or be polymerized under high tempera-
tures during surgery. Ueng et al. (20) described this
advantage for bone repair after tumor removal or infectious
material curettage, such as in osteomyelitis. In addition to
the morphology, the microsphere-shaped implants, in
association with antibiotic drugs, could be candidates for
local antibiotic therapy to prevent and treat bone infections.
In this study, the gradual bone formation was morpholo-
gically and morphometrically assessed. The observed bone
was of a ‘‘membranous’’ type formed independent of cartilage.
Arrote´ia et al. (21) have confirmed that a local vessel supply
and granulation tissue formed by hemorrhagic clots and fibrin
nets are basic requisites for the formation of bone of this type.
The bone healing process involves a series of highly regulated
steps that depend on the interactions of two cell lineages:
the mesenchymal osteoblasts and hematopoietic osteoclasts.
During this process, the bone matrix is deposited in an
irregular manner andwith a definitive form characterized by a
trabecular bone structure that is sculptured or remodeled by
the reabsorptive action of the osteoclasts. This process is
followed by the deposition of new bone via the action of
osteoblastic cells during the following periods until reaching
the thickness of the trabeculae of the local pre-existing bone
bars (21,22). This study demonstrated similar aspects in the
bone healing process. Gradual bone growth was morphologi-
cally and morphometrically proven during the experimental
Figure 5 - Level of maturation of the connective septae formed
around the microspheres (1= loose connective tissue, 2=dense
connective tissue, 3= connective tissue with partial ossification
and 4= total ossification). The periods that showed no values are
equivalent to 0=absent.
Figure 6 - Percentage of bone formation during the different experimental periods for the vancomycin-loaded PLLA/PEO microspheres
and vancomycin-unloaded PLLA/PEO. The periods that showed no values are equivalent to 0=absent.
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periods. Thin trabeculae were observed after four weeks,
followed by a stabilization of the bone formation. The presence
of thin trabeculae can be explained by the osteoclastic activity
in the bone remodeling cycle. This phenomenon was clearly
verified in the previous period analyzed (12 day), which was
followed by osteoblastic activity that was responsible for the
new bone deposition and the progressive trabecular thicken-
ing observed in the successive periods.
According to Raisz (22), after the reabsorption activity by
the osteoclasts during the bone remodeling cycle, there is a
subsequent reversal phase in which mononuclear cells are
present. These cells may complete the reabsorption process
and produce the signals that initiate the bone formation.
Finally, successive waves of mesenchymal cells differentiate
into functional osteoblasts, which lay down thematrix during
the bone formation phase. In our study, this reversal phase
was observed from the eight week until the last experimental
periods in both groups. Complete bone maturation, char-
acterized by lamination of the trabeculae and a return to its
original thickness, was observed in the last period (32weeks).
Ribeiro et al. (23) describe this bone architecture change
during the evaluation of cavities obtained in dogs in an
experimental study of spontaneous bone regeneration. In
this case, from six to ten weeks after the bone formation, an
osteoporotic appearance was observed in the trabecular
bone compared with the appearance in the other periods.
This phenomenon could be related to the osteoclastic
activity. However, the trabecular thickness and distribution
returned to the initial thickness and distribution after 12
weeks. The transition reported in both the study by Ribeiro
et al. and our own study did not impair the lesion healing.
The statistical analyses showed progressive bone forma-
tion during all of the experimental periods. The new bone
growth curve revealed the characteristics of the bone
healing process. These findings were also observed by
Ribeiro et al. (23), who described bone maturation and
lamination with trabecular thickening on the implants after
12 weeks during spontaneous bone regeneration in dogs.
In conclusion, our results demonstrated efficient bone
regeneration using PLLA/PEO blends mixed with vanco-
mycin. In this case, the vancomycin did not impair the bone
healing process when associated with PLLA/PEO micro-
spheres. Further investigation is needed with respect to the
delivery rate of vancomycin from the PLLA/PEO micro-
spheres and its efficacy against microorganisms usually
involved in implant infections. Overall, the vancomycin-
loaded PLLA/PEO microspheres appear to be good candi-
dates as a bone substitute or as an adjuvant for bone repair.
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